Efficacy and safety of urokinase combined with conbercept or triamcinolone acetonide via intravitreal injection in the treatment for vitreous hemorrhage following various retinal disorders

Trial Profile

Efficacy and safety of urokinase combined with conbercept or triamcinolone acetonide via intravitreal injection in the treatment for vitreous hemorrhage following various retinal disorders

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Apr 2018

At a glance

  • Drugs Conbercept (Primary) ; Triamcinolone (Primary) ; Urokinase (Primary)
  • Indications Vitreous haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top